190 related articles for article (PubMed ID: 2936444)
1. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
[TBL] [Abstract][Full Text] [Related]
3. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
Björkholm M; Holm G; Mellstedt H; Pettersson D
Clin Exp Immunol; 1975 Dec; 22(3):373-7. PubMed ID: 131665
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
5. In vitro lymphocyte dysfunction in Hodgkin's disease.
Graze PR; Perlin E; Royston I
J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
[TBL] [Abstract][Full Text] [Related]
9. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
10. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
Begemann M; Claas G; Falke H
Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
Wedelin C; Björkholm M; Holm G; Ogenstad S; Johansson B; Mellstedt H
Br J Cancer; 1982 Jan; 45(1):70-9. PubMed ID: 6977367
[TBL] [Abstract][Full Text] [Related]
13. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
Wagener DJ; Geestman E; Borgonjen A; Haanen C
Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
[TBL] [Abstract][Full Text] [Related]
14. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
Wagener DJ; Geestman E; Wessels HM
Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease.
Björkholm M; Wedelin C; Holm G; Ericsson H; Nilsson P; Mellstedt H
Cancer; 1982 Nov; 50(10):2044-8. PubMed ID: 7127249
[TBL] [Abstract][Full Text] [Related]
16. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
[TBL] [Abstract][Full Text] [Related]
17. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
[TBL] [Abstract][Full Text] [Related]
18. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
19. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
20. Immunologic profile of patients with cured Hodgkin's disease.
Bjorkholm M; Holm G; Mellstedt H
Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
